CHEYENNE, WY / ACCESSWIRE / February 18, 2021 / MJ Biotech, Inc. (OTCQB:MJTV), is pleased to announce its partner, Genesis Botanical Research (GBR), an MJTV Wholly Owned Subsidiary, took in the delivery of CBD extraction equipment. The post-secondary extraction lines are being erected at a temporary satellite location for assembly and fine-tuning. These lines will be moved to the Maine extraction facility once the structure is complete.

As previously disclosed, the site of the facility is located in Sagadahoc County in Mid-Coast Central Maine on an agricultural plot of land. No time is being wasted as Genesis Botanical is and will perform tasks ahead of time, such as these CBD extractions lines, so there is no dead time between the necessary steps needed to be taken to have the facility operational.

GBR executives and project managers have been traveling throughout the United States over the past several months researching the latest technology in CBD extraction equipment to ensure MJTV produces the highest quality CBD at the lowest costs possible to ensure high profit margins.

For additional information please contact us at info@mjbiotech.us .

Safe Harbor Statement: Some of the statements in this press release may be forward-looking statements or statements of future expectations based on currently available information. Such statements are naturally subject to risks and uncertainties. Factors such as the development of general economic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements. MJ Biotech Inc. does not make any representation or warranty, express or implied, as to the accuracy, completeness, or updated status of such statements. Therefore, in no case whatsoever will MJ Biotech. Inc. and its affiliate companies be liable to anyone for any decision made or action taken in conjunction with the information and/or statements in this press release or for any related damages.

SOURCE: MJ Biotech, Inc.